Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Timing bond allocations can reduce risk and stabilize income in retirement. Learn indicators and phased approaches to use bonds effectively.
22,161 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
The Roundhill Memory ETF fell roughly 5% in early trading after a dramatic six-week breakout. Analysts say profit-tak...
A new ETF from Alpha Architect is drawing attention for tax-driven gains. BOXX aims to cut taxes for high earners by ...
Battery-focused BATT has surged past the SPY, led by a year of strong gains in battery metals and EV supply chains.
Bitwise CIO Matt Hougan argues that Strategy's STRC selloff reflects end-of-cycle deleveraging preceding a bitcoin bo...
Colorado unveils a sweeping plan to fix the battery recycling economics problem by funding a statewide recycling prog...
Strategy continues to deploy capital into Bitcoin as market dynamics evolve, highlighting the tension between bold cr...
Terex stock surged nearly 70% in the last year, fueling headlines about strong demand in construction and industrial ...
Webull rolled out a March 2026 cash-bonuses program, offering tiered deposit matches and a first-transfer reimburseme...
Institutional appetite for bitcoin ETFs intensified, with roughly $1.15 billion flowing in over the latest week and a...
In May 2026, Invesco's PDBC uses a Cayman wrapper to avoid K-1 forms while pursuing broad commodity exposure. Yet a p...
Anthropic filed confidentially for an IPO on June 1, 2026, signaling a landmark tech debut. For individual investors,...